Fuelled by media scrutiny, drug affordability is becoming an increasingly powerful influence in market access decisions today. Learn how to overcome it.

Lean Biotechs and patients themselves are using new technology to revolutionise the patient experience. In order to keep up, Pharma needs to significantly accelerate and strengthen its value proposition in the digital space.

Your monthly compilation of regulatory news from around the globe. Follow the link to read March's edition from Kinapse.

Health Canada have drafted a guidance document relating to the planned public release of clinical trial documents, broadly in line with EMA Policy 0070. What are the key differences? How should your organisation prepare?

Plain language summaries of clinical study reports must be understood by lay readers and clinical experts. How should organisations strike the balance?

Your monthly compilation of regulatory news from around the globe. Follow the link to read March's edition from Kinapse.

A recently announced FDA pilot program suggests that the agency is taking steps towards implementing an equivalent to the EMA's policy 0070. US-based organisations should act now to prepare.

With the Life Sciences industry playing catch-up on AI, how are industry leaders narrowing the gap? John Cogan, Head of innovation, shares his views.